Patients with mitral and tricuspid heart valve disease often have complex conditions with limited treatment options. Our Transcatheter Mitral and Tricuspid Therapies (TMTT) business unit is boldly pursuing an innovative portfolio of technologies to address a patient’s unmet clinical needs. It’s our driving force to help patients live longer and healthier lives. Join us and be part of our inspiring journey.
Deliver **clinical education and operational expertise by providing education and training support** **within a specific modality or product portfolio** to clinical end-users.
**How you'll make an impact:**
• Act as a lead on all aspects within the therapy including imaging, integration and troubleshooting techniques related to equipment, software, tools and products required for clinical use including but not limited to intraoperative case coverage and coordinating one-on-one ad hoc training...